CX-072, a PD-L1 Probody therapeutic, as monotherapy in patients with advanced solid tumors: preliminary results of PROCLAIM-CX-072
Naing, A Thistlethwaite, Fiona C Spira, AI Garcia-Corbacho, J Randhawa, M Eskens, F O'Neil, B Lavernia, J Uboha, NV Hamid, O
Naing, A
Thistlethwaite, Fiona C
Spira, AI
Garcia-Corbacho, J
Randhawa, M
Eskens, F
O'Neil, B
Lavernia, J
Uboha, NV
Hamid, O
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Naing A, Thistlethwaite FC, Spira AI, Garcia-Corbacho J, Randhawa M, Eskens F, et al. CX-072, a PD-L1 Probody therapeutic, as monotherapy in patients with advanced solid tumors: preliminary results of PROCLAIM-CX-072. J Clin Oncol. 2019;37(15_suppl):2513-.